Cargando…

Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels

Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadross, Michael R., Johny, Manu Ben, Yue, David T.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828906/
https://www.ncbi.nlm.nih.gov/pubmed/20142517
http://dx.doi.org/10.1085/jgp.200910308
_version_ 1782178039908532224
author Tadross, Michael R.
Johny, Manu Ben
Yue, David T.
author_facet Tadross, Michael R.
Johny, Manu Ben
Yue, David T.
author_sort Tadross, Michael R.
collection PubMed
description Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-lid occlusion of channels, selectivity filter collapse, and allosteric inhibition of the activation gate. Here, novel theory predicts that perturbations of channel activation should alter inactivation in distinctive ways, depending on which hypothesis holds true. Thus, we systematically mutate the activation gate, formed by all S6 segments within Ca(V)1.3. These channels feature robust baseline CDI, and the resulting mutant library exhibits significant diversity of activation, CDI, and VDI. For CDI, a clear and previously unreported pattern emerges: activation-enhancing mutations proportionately weaken inactivation. This outcome substantiates an allosteric CDI mechanism. For VDI, the data implicate a “hinged lid–shield” mechanism, similar to a hinged-lid process, with a previously unrecognized feature. Namely, we detect a “shield” in Ca(V)1.3 channels that is specialized to repel lid closure. These findings reveal long-sought downstream mechanisms of inactivation and may furnish a framework for the understanding of Ca(2+) channelopathies involving S6 mutations.
format Text
id pubmed-2828906
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-28289062010-09-01 Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels Tadross, Michael R. Johny, Manu Ben Yue, David T. J Gen Physiol Article Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-lid occlusion of channels, selectivity filter collapse, and allosteric inhibition of the activation gate. Here, novel theory predicts that perturbations of channel activation should alter inactivation in distinctive ways, depending on which hypothesis holds true. Thus, we systematically mutate the activation gate, formed by all S6 segments within Ca(V)1.3. These channels feature robust baseline CDI, and the resulting mutant library exhibits significant diversity of activation, CDI, and VDI. For CDI, a clear and previously unreported pattern emerges: activation-enhancing mutations proportionately weaken inactivation. This outcome substantiates an allosteric CDI mechanism. For VDI, the data implicate a “hinged lid–shield” mechanism, similar to a hinged-lid process, with a previously unrecognized feature. Namely, we detect a “shield” in Ca(V)1.3 channels that is specialized to repel lid closure. These findings reveal long-sought downstream mechanisms of inactivation and may furnish a framework for the understanding of Ca(2+) channelopathies involving S6 mutations. The Rockefeller University Press 2010-03 /pmc/articles/PMC2828906/ /pubmed/20142517 http://dx.doi.org/10.1085/jgp.200910308 Text en © 2010 Tadross et al. https://creativecommons.org/licenses/by-nc-sa/3.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/) ).
spellingShingle Article
Tadross, Michael R.
Johny, Manu Ben
Yue, David T.
Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title_full Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title_fullStr Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title_full_unstemmed Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title_short Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
title_sort molecular endpoints of ca(2+)/calmodulin- and voltage-dependent inactivation of ca(v)1.3 channels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828906/
https://www.ncbi.nlm.nih.gov/pubmed/20142517
http://dx.doi.org/10.1085/jgp.200910308
work_keys_str_mv AT tadrossmichaelr molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels
AT johnymanuben molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels
AT yuedavidt molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels